R&D Job Losses Bad News
Wednesday 2nd February 2012
ASTRA ZENECA JOB
LOSSES ARE BAD NEWS AS THESE CUTTING EDGE R&D JOBS ARE BOTH
WELL PAID AND ESSENTIAL FOR A THRIVING UK ECONOMY
As a nation we do
need to find a viable way to continue to make breakthroughs in
bringing to safe use much needed new medicines says
GMB
GMB, the unions for pharmaceutical workers, responded to the
announcement by Anglo-Swedish drug maker Astra Zeneca that 7,300
jobs around the world will be cut over the next two years
Allan Black GMB National
Officer said "Astra Zeneca told me that between 250 and 350
research and development jobs will be lost at the Alderley Park
site and some further backroom jobs will be lost at some of the
other locations. GMB and other unions will meet with Astra Zeneca
to discuss this announcement and the prospects for jobs across all
sites in the UK.
This is very bad
news for the UK economy. These cutting edge R&D jobs are both
well paid and essential for a thriving UK economy. As a nation we
do need to find a viable way to continue to make breakthroughs in
bringing to safe use much needed new medicines."
End
Contact: Allan Black, GMB National Officer on 07725 100316 or Eddie
Parker in GMB North West on 07740 8040 46 or GMB Press Office on
07921 289880 or 07974 251823